Regencell Bioscience Holdings Ltd is 4.0x more valuable than Definium Therapeutics, Inc. by market capitalization ($10.11 B vs $2.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DFTX | RGC |
|---|---|---|
| Market cap | $2.53 B | $10.11 B |
| US-listed rank | #1936 | #936 |
| Net income (latest FY) | -$183.79M | -$3.58M |
| SEC filings | 445 | 82 |
Regencell Bioscience Holdings Ltd is 4.0x more valuable than Definium Therapeutics, Inc. by market capitalization ($10.11 B vs $2.53 B).
Full pages: Definium Therapeutics, Inc. and Regencell Bioscience Holdings Ltd, or browse the full rankings.